Kiwa Announces strategic relationship with Chuon Co., LTD,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Kiwa Announces strategic relationship with Chuon Co., LTD, of Japan

CLAREMONT, Calif., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCQB:KWBT) (“Kiwa” or the “Company”) is pleased to announce that Japanese Chuon Co., LTD (the “Chuon Company”) visited Kiwa Bio-Tech (Beijing) Co., LTD in Beijing recently to discuss the role of biotechnology in agriculture and advanced methods of controlling “desert”-ification. Desertification is the process by which fertile land becomes desert, typically as a result of drought, deforestation, or inappropriate agriculture.             

“In recent years we have witnessed a robust development in China’s bio-fertilizer industry. There is a strong trend towards developing health and safety in soil and agricultural products,” stated Mr. Osawa Kunio, the CEO of Chuon Company. Mr. Osawa applauded the Chinese government’s commitment to soil protection. He also suggested that, as a rapidly growing enterprise with sixteen-years of experience in developing and marketing bio-fertilizers, Kiwa has great potential to become one of the leading bio-fertilizer enterprises in China. Chuon Company has expressed a desire to share its experience with Kiwa regarding biotechnology and soil recovery.

Mr. Song Yong Lin, Kiwa’s CTO and Technical director stated that “Japan is an eco-friendly country, which prioritizes environmental protection and has a mature system of soil remediation. Japan has great experience in biotechnological application and education, which Kiwa can deploy in its own markets.” Japan enjoys a forest coverage rate of up to 67%, which is higher than many other developed countries. Considering the similar geography and climates of China and Japan, Kiwa wishes to follow Japan’s successful experience in soil and apply it to the anti-“desert”-ification project of the China Foundation for Desertification Control. Kiwa believes that these efforts by China represent a multi-billion dollar revenue opportunity.

Both companies agreed to integrate each other’s microbial technologies and establish a practical framework to enhance international awareness. Kiwa is excited about this opportunity as it opens a new business vertical for the Company – their traditional agricultural business will now be paired with a soil preservation division that will be driven by Government policy and budget. This development will help drive growth and facilitate the use of Kiwa’s recently acquired production capacity. Kiwa believes that the first revenues that can be generated from this initiative will be in the second quarter of 2017.

About Chuon Co., LTD. Chuon Co., LTD. was established in April 1956, located in Matsuyama, Ehime Prefecture, Japan. Chuon Company currently has offices in Beijing and Shanghai China. Since 1989, Chuon has owned its own manufacturing facility named Tsuyoshi in Matsuyama. Over the past decades, Chuon has focused on the fields of microbial technology, manufacturing and processing of agricultural foods and companies with many patents.

  About Chinese Desertification Control Foundation (CFDC) 

The foundation helps combat desertification in China. Conservation International Mission is to conserve the earth's biodiversity.

About Kiwa Bio-Tech Products Group Corporation

We develop, manufacture, distribute and market innovative, cost-effective and eco-friendly bio-technological products for agriculture. Our main product groups are bio-fertilizer and biologically enhanced livestock feed. Our products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. Our businesses include bio-fertilizer and bio-enhanced feed.

Kiwa’s strategy is to implement increased visibility for marketing Kiwa’s current bio-fertilizer products, together with the development of a “green agriculture” safe food platform in China. Our goal is to build market penetration for our Kiwa brand in China’s trillion dollar “green” agricultural produce market.

For more information on Kiwa and its products, please refer to the Company’s website at www.kiwabiotech.com or the Company filings with the United States Securities and Exchange Commission, available for free at www.sec.gov .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

CONTACT:       Kiwa Bio-Tech Products Group Corporation Yvonne Wang yvonne@kiwabiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading